📌 Key Takeaways
- Topic: Fused Silica Powder: Purity, Particle Sizes, CTE and Electronic Applications
- Keywords: Covia silica
- Published: 2026-11-20 00:59:13
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Powder Supplier Guide: How to Compare Grades, Quality and Pricing
- Silica Sol Manufacturer: Product Types, Quality Control and How to Choose
- HD Silica Explained: Highly Dispersible Silica Specs, Benefits and Tire Applications
- Mesoporous carriers also offer an attractive alternative in the oral therapy of macromolecules rather than the more complicated parenteral administration. Peptides and proteins may denature in the greatly acidic environment of the stomach, lose their structure and function [ 1, 13 ], while the proteases in the digestive system break down the protein chains, making the molecule useless and the therapy ineffective [ 1, 13, 91 ]. Additionally, poor permeation through the epithelium is another hindering component during the oral administration of macromolecules [ 1, 13 ]. The macromolecule locked inside the pores stays protected against enzymatic or chemical degradation, and its permeation through the epithelium can also be improved [ 1, 13, 91 ]. It is also true that smaller pores deliver better protection for macromolecules against degradation [ 1 ]. Mesoporous silica nanocarriers have extra intriguing advantages because of their special properties that make them outstanding over other carriers and therefore provide a popular alternative in formulating macromolecules [ 1, 13 ].
- Silica as a Rheology Modifier: How It Controls Viscosity and Flow
- Silicon Dioxide in Food: Why It Is Added and Whether It Is Safe
Spherical Silica Powder: Specifications, Particle Sizes and How to Choose the Right Grade
What is silica (SiO₂)?
highly dispersible silica
What is the difference between fumed silica and precipitated silica?
quartz sand for photovoltaic
What drives silica raw material prices?
amorphous vs crystalline silica MSNs are also appropriate for pulmonary drug delivery. Inhalation is an attractive route of administration since the application is non-invasive and patient-friendly [ 18 ]. However, the rapid mucociliary clearance and the mucus hurdle complicate the intake of the API and are obstacles to be overcome [ 18, 25 ]. The mesoporous drug delivery systems may be really helpful in the treatment of lung diseases, as they can passively accumulate in the alveoli [ 25, 56, 72 ]. The passive accumulation is due to their small size, while the sizable surface area, high vascularity, and vascular permeability of the lungs enhance the process [ 56 ]. Furthermore, targeted treatment of tumors or inflamed cells can also be implemented with the functionalization of their surface [ 56, 72 ]. MSNs are typically delivered to the lungs in powder form with dry powder inhalers or suspended in liquid droplets with a nebulizer [ 56 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.